Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiac Catheterization | 15 | 2019 | 291 | 4.720 |
Why?
|
Heart-Assist Devices | 11 | 2018 | 731 | 3.030 |
Why?
|
Heart Arrest | 13 | 2018 | 265 | 2.250 |
Why?
|
Aortic Valve Insufficiency | 5 | 2017 | 130 | 2.200 |
Why?
|
Septal Occluder Device | 11 | 2020 | 42 | 2.170 |
Why?
|
Ventricular Fibrillation | 10 | 2016 | 65 | 2.010 |
Why?
|
Myocardial Infarction | 9 | 2024 | 376 | 1.980 |
Why?
|
Cardiopulmonary Resuscitation | 9 | 2019 | 190 | 1.930 |
Why?
|
Shock, Cardiogenic | 5 | 2016 | 95 | 1.930 |
Why?
|
Myocardial Ischemia | 7 | 2024 | 162 | 1.910 |
Why?
|
Heart Valve Prosthesis Implantation | 6 | 2023 | 166 | 1.710 |
Why?
|
Extracorporeal Membrane Oxygenation | 5 | 2019 | 139 | 1.680 |
Why?
|
Coronary Vessels | 8 | 2024 | 177 | 1.630 |
Why?
|
Echocardiography, Transesophageal | 11 | 2020 | 344 | 1.600 |
Why?
|
Heart Septal Defects, Ventricular | 3 | 2019 | 67 | 1.570 |
Why?
|
Ventricular Function, Left | 7 | 2021 | 592 | 1.530 |
Why?
|
Coronary Angiography | 15 | 2024 | 232 | 1.520 |
Why?
|
Popliteal Artery | 2 | 2020 | 27 | 1.480 |
Why?
|
Absorbable Implants | 2 | 2020 | 34 | 1.460 |
Why?
|
Heart Failure | 9 | 2021 | 1204 | 1.450 |
Why?
|
Angioplasty, Balloon | 2 | 2020 | 95 | 1.420 |
Why?
|
Peripheral Arterial Disease | 2 | 2020 | 88 | 1.360 |
Why?
|
Ischemia | 2 | 2020 | 243 | 1.280 |
Why?
|
Treatment Outcome | 34 | 2024 | 7990 | 1.220 |
Why?
|
Cardiac Surgical Procedures | 5 | 2019 | 462 | 1.120 |
Why?
|
Percutaneous Coronary Intervention | 6 | 2020 | 58 | 1.080 |
Why?
|
Aortic Valve | 4 | 2023 | 222 | 1.070 |
Why?
|
Angioplasty, Balloon, Coronary | 8 | 2012 | 66 | 1.070 |
Why?
|
Endothelin-1 | 3 | 2011 | 41 | 1.060 |
Why?
|
Out-of-Hospital Cardiac Arrest | 4 | 2020 | 67 | 1.040 |
Why?
|
Aortic Valve Stenosis | 5 | 2023 | 131 | 1.030 |
Why?
|
Coronary Artery Disease | 6 | 2024 | 350 | 1.010 |
Why?
|
Ultrasonography, Interventional | 3 | 2023 | 121 | 1.000 |
Why?
|
Prosthesis Design | 7 | 2019 | 278 | 0.870 |
Why?
|
Male | 53 | 2022 | 40958 | 0.860 |
Why?
|
Endovascular Procedures | 2 | 2017 | 218 | 0.850 |
Why?
|
Pulmonary Embolism | 6 | 2021 | 222 | 0.850 |
Why?
|
Echocardiography, Three-Dimensional | 6 | 2020 | 516 | 0.840 |
Why?
|
Thrombolytic Therapy | 5 | 2021 | 220 | 0.810 |
Why?
|
Arrhythmias, Cardiac | 2 | 2017 | 187 | 0.810 |
Why?
|
Stents | 4 | 2012 | 377 | 0.780 |
Why?
|
Catheterization | 4 | 2017 | 232 | 0.780 |
Why?
|
Humans | 68 | 2024 | 86617 | 0.770 |
Why?
|
Middle Aged | 28 | 2020 | 25017 | 0.720 |
Why?
|
Hemodynamics | 5 | 2013 | 710 | 0.720 |
Why?
|
Registries | 5 | 2020 | 702 | 0.700 |
Why?
|
Aged | 27 | 2020 | 18402 | 0.670 |
Why?
|
Retrospective Studies | 21 | 2023 | 8477 | 0.670 |
Why?
|
Hospital Costs | 1 | 2019 | 104 | 0.640 |
Why?
|
Vena Cava, Superior | 1 | 2018 | 59 | 0.620 |
Why?
|
Coronary Artery Bypass | 3 | 2023 | 228 | 0.620 |
Why?
|
Balloon Occlusion | 3 | 2012 | 27 | 0.620 |
Why?
|
Acute Coronary Syndrome | 1 | 2018 | 45 | 0.620 |
Why?
|
Clinical Protocols | 1 | 2018 | 156 | 0.620 |
Why?
|
Computed Tomography Angiography | 2 | 2020 | 131 | 0.620 |
Why?
|
Coronary Vessel Anomalies | 1 | 2018 | 41 | 0.610 |
Why?
|
Arteriovenous Fistula | 1 | 2018 | 52 | 0.610 |
Why?
|
Heart Ventricles | 2 | 2020 | 760 | 0.610 |
Why?
|
Blood Circulation | 1 | 2017 | 29 | 0.610 |
Why?
|
Heart Massage | 1 | 2017 | 12 | 0.600 |
Why?
|
Venae Cavae | 1 | 2017 | 14 | 0.600 |
Why?
|
Swine | 13 | 2016 | 555 | 0.600 |
Why?
|
Transposition of Great Vessels | 1 | 2017 | 23 | 0.600 |
Why?
|
Prosthesis Implantation | 1 | 2018 | 125 | 0.600 |
Why?
|
Aminophylline | 1 | 2016 | 14 | 0.590 |
Why?
|
Device Removal | 1 | 2018 | 161 | 0.590 |
Why?
|
Bradycardia | 1 | 2016 | 39 | 0.590 |
Why?
|
Female | 37 | 2022 | 44509 | 0.580 |
Why?
|
Heart Septal Defects | 1 | 2016 | 31 | 0.580 |
Why?
|
Fibrinolytic Agents | 3 | 2021 | 202 | 0.570 |
Why?
|
Cardiomyopathies | 2 | 2018 | 240 | 0.570 |
Why?
|
Prosthesis Failure | 1 | 2017 | 111 | 0.570 |
Why?
|
Dyspnea | 1 | 2016 | 73 | 0.560 |
Why?
|
Constriction, Pathologic | 1 | 2017 | 213 | 0.560 |
Why?
|
Postoperative Complications | 3 | 2017 | 2207 | 0.550 |
Why?
|
Balloon Valvuloplasty | 1 | 2015 | 8 | 0.550 |
Why?
|
Organ Dysfunction Scores | 1 | 2016 | 27 | 0.550 |
Why?
|
Disease Management | 1 | 2018 | 327 | 0.540 |
Why?
|
Vascular Fistula | 1 | 2015 | 12 | 0.540 |
Why?
|
Surgery, Computer-Assisted | 1 | 2016 | 99 | 0.530 |
Why?
|
Defibrillators, Implantable | 1 | 2017 | 129 | 0.530 |
Why?
|
Fontan Procedure | 1 | 2015 | 53 | 0.520 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2020 | 134 | 0.510 |
Why?
|
Practice Guidelines as Topic | 3 | 2018 | 1034 | 0.510 |
Why?
|
Ventricular Septum | 1 | 2014 | 11 | 0.510 |
Why?
|
Pulmonary Veins | 1 | 2015 | 72 | 0.510 |
Why?
|
Heart Injuries | 1 | 2014 | 16 | 0.500 |
Why?
|
Electrocardiography | 4 | 2012 | 478 | 0.500 |
Why?
|
Epinephrine | 2 | 2011 | 84 | 0.490 |
Why?
|
Iatrogenic Disease | 1 | 2014 | 69 | 0.490 |
Why?
|
Adenosine | 1 | 2016 | 225 | 0.480 |
Why?
|
Time Factors | 10 | 2021 | 5209 | 0.480 |
Why?
|
Aneurysm, False | 1 | 2014 | 54 | 0.470 |
Why?
|
Echocardiography, Doppler, Color | 4 | 2015 | 103 | 0.460 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2014 | 87 | 0.440 |
Why?
|
Embolization, Therapeutic | 1 | 2015 | 238 | 0.440 |
Why?
|
Risk Assessment | 8 | 2020 | 2261 | 0.430 |
Why?
|
Heart Defects, Congenital | 1 | 2015 | 351 | 0.430 |
Why?
|
Foramen Ovale, Patent | 1 | 2012 | 18 | 0.430 |
Why?
|
Biomarkers | 3 | 2019 | 1718 | 0.410 |
Why?
|
Tissue Plasminogen Activator | 1 | 2013 | 162 | 0.400 |
Why?
|
Aged, 80 and over | 9 | 2020 | 6501 | 0.400 |
Why?
|
Thymosin | 1 | 2011 | 6 | 0.400 |
Why?
|
Coronary Aneurysm | 1 | 2011 | 16 | 0.390 |
Why?
|
Polytetrafluoroethylene | 1 | 2011 | 74 | 0.390 |
Why?
|
Electric Countershock | 2 | 2011 | 47 | 0.390 |
Why?
|
Death, Sudden, Cardiac | 1 | 2011 | 45 | 0.390 |
Why?
|
Respiratory Insufficiency | 1 | 2012 | 150 | 0.380 |
Why?
|
Coronary Disease | 2 | 2012 | 261 | 0.370 |
Why?
|
Vascular Patency | 2 | 2020 | 126 | 0.360 |
Why?
|
Disease Models, Animal | 10 | 2016 | 2232 | 0.360 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 183 | 0.360 |
Why?
|
Mitral Valve | 3 | 2020 | 248 | 0.350 |
Why?
|
Obesity, Morbid | 1 | 2012 | 225 | 0.350 |
Why?
|
After-Hours Care | 1 | 2008 | 8 | 0.340 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2011 | 407 | 0.340 |
Why?
|
Severity of Illness Index | 5 | 2019 | 1801 | 0.330 |
Why?
|
Coronary Thrombosis | 1 | 2008 | 14 | 0.320 |
Why?
|
Mitral Valve Insufficiency | 3 | 2020 | 187 | 0.310 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2007 | 11 | 0.310 |
Why?
|
Medical Errors | 1 | 2008 | 115 | 0.310 |
Why?
|
Coronary Circulation | 3 | 2024 | 130 | 0.300 |
Why?
|
United States | 7 | 2020 | 6665 | 0.300 |
Why?
|
Hypoxia | 1 | 2012 | 641 | 0.290 |
Why?
|
Risk Factors | 8 | 2021 | 5417 | 0.290 |
Why?
|
Follow-Up Studies | 5 | 2019 | 3636 | 0.290 |
Why?
|
Thrombectomy | 1 | 2008 | 158 | 0.290 |
Why?
|
Predictive Value of Tests | 5 | 2018 | 1673 | 0.280 |
Why?
|
Circadian Rhythm | 1 | 2008 | 303 | 0.280 |
Why?
|
Quality Assurance, Health Care | 1 | 2007 | 220 | 0.270 |
Why?
|
Adult | 11 | 2024 | 25640 | 0.270 |
Why?
|
Artifacts | 1 | 2007 | 244 | 0.260 |
Why?
|
Health Services Accessibility | 1 | 2008 | 394 | 0.260 |
Why?
|
Intra-Aortic Balloon Pumping | 2 | 2015 | 78 | 0.250 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2008 | 378 | 0.250 |
Why?
|
Cost-Benefit Analysis | 2 | 2019 | 451 | 0.250 |
Why?
|
Peripheral Vascular Diseases | 1 | 2004 | 62 | 0.250 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2007 | 332 | 0.250 |
Why?
|
Hyperlipidemias | 1 | 2004 | 95 | 0.250 |
Why?
|
Heart Transplantation | 2 | 2023 | 705 | 0.240 |
Why?
|
Cysteine | 1 | 2024 | 135 | 0.230 |
Why?
|
Heart Diseases | 2 | 2016 | 290 | 0.230 |
Why?
|
Clinical Competence | 1 | 2008 | 751 | 0.220 |
Why?
|
Microcirculation | 2 | 2024 | 106 | 0.210 |
Why?
|
Ulnar Artery | 1 | 2022 | 5 | 0.210 |
Why?
|
Antibodies, Monoclonal | 4 | 2013 | 1376 | 0.210 |
Why?
|
Survival Rate | 5 | 2019 | 1860 | 0.210 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2013 | 683 | 0.210 |
Why?
|
Radial Artery | 1 | 2022 | 33 | 0.210 |
Why?
|
Aorta | 2 | 2020 | 280 | 0.200 |
Why?
|
Stroke Volume | 3 | 2021 | 456 | 0.200 |
Why?
|
Cardiovascular Diseases | 2 | 2007 | 827 | 0.200 |
Why?
|
Acute Disease | 3 | 2021 | 826 | 0.190 |
Why?
|
Gene Expression Regulation | 2 | 2009 | 1920 | 0.190 |
Why?
|
Transillumination | 1 | 2020 | 9 | 0.190 |
Why?
|
Limb Salvage | 1 | 2020 | 31 | 0.190 |
Why?
|
Ultrasonography | 3 | 2015 | 695 | 0.190 |
Why?
|
Reoperation | 2 | 2013 | 597 | 0.190 |
Why?
|
ST Elevation Myocardial Infarction | 1 | 2020 | 11 | 0.180 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2011 | 78 | 0.180 |
Why?
|
Resuscitation | 2 | 2011 | 100 | 0.180 |
Why?
|
Recovery of Function | 2 | 2018 | 272 | 0.180 |
Why?
|
Animals | 14 | 2016 | 26582 | 0.180 |
Why?
|
Coronary Restenosis | 3 | 2010 | 11 | 0.170 |
Why?
|
Fluoroscopy | 1 | 2019 | 119 | 0.170 |
Why?
|
Venous Thrombosis | 1 | 2021 | 243 | 0.170 |
Why?
|
Saphenous Vein | 2 | 2010 | 61 | 0.160 |
Why?
|
Quality-Adjusted Life Years | 1 | 2019 | 138 | 0.160 |
Why?
|
Monocytes | 1 | 2019 | 214 | 0.160 |
Why?
|
Echocardiography | 4 | 2020 | 911 | 0.160 |
Why?
|
Microvessels | 1 | 2018 | 70 | 0.160 |
Why?
|
Recurrence | 2 | 2012 | 1139 | 0.160 |
Why?
|
Arterial Switch Operation | 1 | 2017 | 5 | 0.150 |
Why?
|
Triage | 1 | 2018 | 108 | 0.150 |
Why?
|
Purinergic P1 Receptor Antagonists | 1 | 2016 | 6 | 0.150 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2016 | 5 | 0.150 |
Why?
|
Minimally Invasive Surgical Procedures | 2 | 2016 | 237 | 0.150 |
Why?
|
Renal Veins | 1 | 2017 | 28 | 0.150 |
Why?
|
Glomerular Filtration Rate | 1 | 2018 | 384 | 0.150 |
Why?
|
Emergency Service, Hospital | 3 | 2016 | 484 | 0.150 |
Why?
|
Tumor Necrosis Factors | 1 | 2016 | 14 | 0.150 |
Why?
|
Heart Atria | 2 | 2016 | 250 | 0.150 |
Why?
|
Vascular Surgical Procedures | 1 | 2018 | 148 | 0.140 |
Why?
|
Foreign-Body Migration | 1 | 2017 | 35 | 0.140 |
Why?
|
Decision Support Techniques | 1 | 2018 | 160 | 0.140 |
Why?
|
Bioprosthesis | 1 | 2016 | 36 | 0.140 |
Why?
|
Transcatheter Aortic Valve Replacement | 1 | 2017 | 47 | 0.140 |
Why?
|
Macrophages | 1 | 2019 | 554 | 0.140 |
Why?
|
Chronic Disease | 1 | 2019 | 971 | 0.140 |
Why?
|
Cannula | 1 | 2016 | 47 | 0.140 |
Why?
|
Databases, Factual | 1 | 2019 | 812 | 0.140 |
Why?
|
Equipment Failure | 1 | 2016 | 119 | 0.140 |
Why?
|
Length of Stay | 1 | 2019 | 700 | 0.130 |
Why?
|
Subclavian Artery | 1 | 2015 | 44 | 0.130 |
Why?
|
Vena Cava Filters | 1 | 2017 | 96 | 0.130 |
Why?
|
Atrial Appendage | 1 | 2015 | 26 | 0.130 |
Why?
|
Prognosis | 3 | 2020 | 3675 | 0.130 |
Why?
|
Acute Kidney Injury | 1 | 2018 | 295 | 0.130 |
Why?
|
Random Allocation | 4 | 2020 | 332 | 0.120 |
Why?
|
Comorbidity | 2 | 2015 | 943 | 0.120 |
Why?
|
Hyperthermia, Induced | 1 | 2014 | 72 | 0.120 |
Why?
|
Aortography | 1 | 2014 | 63 | 0.120 |
Why?
|
Blood Transfusion, Autologous | 1 | 2013 | 16 | 0.120 |
Why?
|
Infusions, Parenteral | 1 | 2013 | 50 | 0.120 |
Why?
|
Amiodarone | 1 | 2013 | 12 | 0.120 |
Why?
|
Contrast Media | 1 | 2018 | 1078 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 3357 | 0.120 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2013 | 68 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 4 | 2017 | 2601 | 0.110 |
Why?
|
International Normalized Ratio | 1 | 2013 | 38 | 0.110 |
Why?
|
Dobutamine | 1 | 2013 | 61 | 0.110 |
Why?
|
Reproducibility of Results | 4 | 2018 | 2705 | 0.110 |
Why?
|
Thrombosis | 1 | 2016 | 296 | 0.110 |
Why?
|
Heart | 2 | 2020 | 539 | 0.110 |
Why?
|
Pulsatile Flow | 1 | 2013 | 49 | 0.110 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2013 | 58 | 0.110 |
Why?
|
Software | 1 | 2017 | 654 | 0.110 |
Why?
|
Catheter Ablation | 1 | 2015 | 233 | 0.110 |
Why?
|
Kidney | 1 | 2018 | 1241 | 0.110 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2013 | 108 | 0.110 |
Why?
|
Whole Blood Coagulation Time | 1 | 2012 | 6 | 0.110 |
Why?
|
Patient Care Team | 1 | 2014 | 280 | 0.110 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2017 | 663 | 0.110 |
Why?
|
Exercise Test | 1 | 2013 | 164 | 0.110 |
Why?
|
Survival Analysis | 1 | 2016 | 1538 | 0.110 |
Why?
|
Mitral Valve Stenosis | 1 | 2012 | 37 | 0.100 |
Why?
|
Labetalol | 1 | 2011 | 6 | 0.100 |
Why?
|
Metoprolol | 1 | 2011 | 30 | 0.100 |
Why?
|
Vascular Resistance | 2 | 2024 | 102 | 0.100 |
Why?
|
Atrial Fibrillation | 1 | 2015 | 288 | 0.100 |
Why?
|
Radiography, Interventional | 1 | 2012 | 150 | 0.100 |
Why?
|
Catheters | 2 | 2021 | 74 | 0.100 |
Why?
|
California | 2 | 2010 | 138 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 2012 | 141 | 0.100 |
Why?
|
Regenerative Medicine | 1 | 2011 | 23 | 0.100 |
Why?
|
Infliximab | 4 | 2013 | 151 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 864 | 0.100 |
Why?
|
Immunoglobulin G | 1 | 2013 | 456 | 0.100 |
Why?
|
Vasopressins | 1 | 2010 | 49 | 0.100 |
Why?
|
Drug-Eluting Stents | 1 | 2010 | 16 | 0.100 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 243 | 0.090 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2011 | 152 | 0.090 |
Why?
|
Monitoring, Physiologic | 1 | 2012 | 268 | 0.090 |
Why?
|
Ventricular Remodeling | 1 | 2011 | 96 | 0.090 |
Why?
|
Graft Occlusion, Vascular | 1 | 2010 | 99 | 0.090 |
Why?
|
Critical Illness | 1 | 2012 | 294 | 0.090 |
Why?
|
Sirolimus | 1 | 2010 | 169 | 0.090 |
Why?
|
Endothelin-2 | 1 | 2008 | 1 | 0.090 |
Why?
|
Endothelin-3 | 1 | 2008 | 2 | 0.090 |
Why?
|
Ventricular Premature Complexes | 1 | 2008 | 7 | 0.080 |
Why?
|
Electric Stimulation | 1 | 2010 | 347 | 0.080 |
Why?
|
Blood Pressure | 2 | 2013 | 1143 | 0.080 |
Why?
|
Paclitaxel | 1 | 2010 | 460 | 0.080 |
Why?
|
Reperfusion Injury | 1 | 2009 | 131 | 0.080 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 1991 | 0.080 |
Why?
|
Hypertension, Pulmonary | 1 | 2012 | 346 | 0.080 |
Why?
|
Up-Regulation | 1 | 2011 | 712 | 0.080 |
Why?
|
Chicago | 1 | 2013 | 1379 | 0.080 |
Why?
|
Heart Rate | 1 | 2010 | 492 | 0.080 |
Why?
|
Fatigue | 1 | 2008 | 174 | 0.080 |
Why?
|
Workload | 1 | 2008 | 128 | 0.080 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2008 | 93 | 0.080 |
Why?
|
Selection Bias | 1 | 2007 | 37 | 0.080 |
Why?
|
Cell Movement | 1 | 2011 | 758 | 0.080 |
Why?
|
Anticholesteremic Agents | 1 | 2008 | 137 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2008 | 223 | 0.070 |
Why?
|
Coated Materials, Biocompatible | 1 | 2005 | 30 | 0.070 |
Why?
|
Cytokines | 1 | 2009 | 776 | 0.070 |
Why?
|
Coronary Stenosis | 1 | 2005 | 39 | 0.070 |
Why?
|
Observer Variation | 1 | 2007 | 602 | 0.070 |
Why?
|
Metals | 1 | 2005 | 90 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 977 | 0.060 |
Why?
|
Action Potentials | 1 | 2008 | 573 | 0.060 |
Why?
|
Cell Differentiation | 1 | 2011 | 1458 | 0.060 |
Why?
|
Patient Selection | 2 | 2020 | 685 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 508 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2008 | 636 | 0.060 |
Why?
|
Caspases | 1 | 2003 | 155 | 0.060 |
Why?
|
Young Adult | 1 | 2015 | 5974 | 0.060 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2005 | 208 | 0.060 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2003 | 231 | 0.050 |
Why?
|
Spasm | 1 | 2022 | 16 | 0.050 |
Why?
|
Preoperative Care | 2 | 2015 | 394 | 0.050 |
Why?
|
Ventricular Pressure | 1 | 2021 | 34 | 0.050 |
Why?
|
Lower Extremity | 1 | 2021 | 84 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2018 | 1804 | 0.050 |
Why?
|
Tissue Donors | 1 | 2023 | 463 | 0.050 |
Why?
|
Pulmonary Valve | 1 | 2020 | 32 | 0.050 |
Why?
|
Cardiac Output | 1 | 2020 | 156 | 0.050 |
Why?
|
Prospective Studies | 2 | 2018 | 4212 | 0.040 |
Why?
|
Organ Size | 1 | 2020 | 364 | 0.040 |
Why?
|
Prevalence | 1 | 2023 | 1239 | 0.040 |
Why?
|
Hemorrhage | 1 | 2021 | 268 | 0.040 |
Why?
|
Protective Factors | 1 | 2018 | 22 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2021 | 349 | 0.040 |
Why?
|
Hospitals | 1 | 2021 | 294 | 0.040 |
Why?
|
Odds Ratio | 1 | 2020 | 678 | 0.040 |
Why?
|
Anticoagulants | 1 | 2021 | 408 | 0.040 |
Why?
|
Antigens, CD | 1 | 2019 | 458 | 0.040 |
Why?
|
Equipment Design | 1 | 2018 | 406 | 0.040 |
Why?
|
Prosthesis Fitting | 1 | 2017 | 16 | 0.040 |
Why?
|
Anti-Inflammatory Agents | 2 | 2010 | 339 | 0.040 |
Why?
|
Apoptosis | 1 | 2003 | 1683 | 0.040 |
Why?
|
Phlebography | 1 | 2017 | 66 | 0.040 |
Why?
|
Quality of Life | 1 | 2004 | 1583 | 0.040 |
Why?
|
Illinois | 1 | 2018 | 462 | 0.040 |
Why?
|
Oxygen | 1 | 2021 | 726 | 0.030 |
Why?
|
Health Status | 1 | 2018 | 360 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2016 | 293 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2016 | 278 | 0.030 |
Why?
|
Program Evaluation | 1 | 2016 | 297 | 0.030 |
Why?
|
Ultrafiltration | 1 | 2013 | 13 | 0.030 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 350 | 0.030 |
Why?
|
Random Amplified Polymorphic DNA Technique | 1 | 2013 | 6 | 0.030 |
Why?
|
Jehovah's Witnesses | 1 | 2013 | 18 | 0.030 |
Why?
|
Image Enhancement | 1 | 2017 | 563 | 0.030 |
Why?
|
Etanercept | 1 | 2013 | 32 | 0.030 |
Why?
|
Lidocaine | 1 | 2013 | 63 | 0.030 |
Why?
|
Hemoglobins | 1 | 2013 | 179 | 0.030 |
Why?
|
Heart Arrest, Induced | 1 | 2013 | 31 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2013 | 88 | 0.030 |
Why?
|
Cardiopulmonary Bypass | 1 | 2013 | 148 | 0.030 |
Why?
|
Heart Valve Prosthesis | 1 | 2013 | 93 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2013 | 152 | 0.030 |
Why?
|
Reference Values | 1 | 2013 | 674 | 0.030 |
Why?
|
Sus scrofa | 1 | 2011 | 45 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2011 | 229 | 0.020 |
Why?
|
Adrenergic Antagonists | 1 | 2010 | 2 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 307 | 0.020 |
Why?
|
Practice Patterns, Physicians' | 1 | 2016 | 581 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2010 | 78 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 364 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2009 | 154 | 0.020 |
Why?
|
Algorithms | 1 | 2017 | 1830 | 0.020 |
Why?
|
Cardiology Service, Hospital | 1 | 2008 | 4 | 0.020 |
Why?
|
Models, Animal | 1 | 2009 | 263 | 0.020 |
Why?
|
Age Factors | 1 | 2013 | 1849 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2008 | 216 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 858 | 0.020 |
Why?
|
Inflammation | 1 | 2013 | 920 | 0.020 |
Why?
|
Sex Factors | 1 | 2009 | 1054 | 0.020 |
Why?
|
Dilatation, Pathologic | 1 | 2006 | 54 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2008 | 209 | 0.020 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2003 | 25 | 0.020 |
Why?
|
Caspase Inhibitors | 1 | 2003 | 33 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2006 | 912 | 0.010 |
Why?
|
Tunica Intima | 1 | 2003 | 59 | 0.010 |
Why?
|
Hyperplasia | 1 | 2003 | 148 | 0.010 |
Why?
|
Rabbits | 1 | 2003 | 636 | 0.010 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2006 | 466 | 0.010 |
Why?
|
Incidence | 1 | 2005 | 1577 | 0.010 |
Why?
|